Download PDF
Endoscopy 2008; 40(11): 892-898
DOI: 10.1055/s-2008-1077675
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Stepwise radical endoscopic resection for Barrett’s esophagus with early neoplasia: report on a Brussels’ cohort

R.  E.  Pouw1 , F.  P.  Peters1 , C.  Sempoux2 , H.  Piessevaux3 , P.  H.  Deprez3
  • 1Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
  • 2Department of Pathology, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium
  • 3Department of Gastroenterology and Hepatology, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Further Information

Publication History

submitted 12 February 2008

accepted after revision 12 September 2008

Publication Date:
13 November 2008 (online)

Also available at
    Permissions and Reprints

See also:

Commentaire de travail de R. E. Pouw et al., pp. 892Endoscopy 2008; 40(11): 1057-1057
DOI: 10.1055/s-0032-1306884

Background and study aims: The aim of this retrospective study was to assess safety and efficacy of stepwise radical endoscopic resection (SRER) in patients with Barrett’s esophagus with high-grade intraepithelial neoplasia (HGIN) or early cancer.

Patients and methods: Patients undergoing SRER between 2000 and 2006 were retrospectively evaluated. Patients with Barrett’s esophagus who also had HGIN or early cancer were included if they had no signs of submucosal infiltration or metastases. SRER was performed using the cap-technique, at 8-week intervals until all Barrett’s esophagus was removed. Follow-up endoscopy was scheduled every 6 months.

Results: A total of 34 patients were included (31 male, mean 67 years, median Barrett’s dimensions C1M4). HGIN / early cancer was eradicated in all patients in a median of two endoscopic resection sessions (IQR 1–2 sessions). Twelve patients underwent additional argon plasma coagulation for small islets or an irregular Z-line. Barrett’s esophagus was eradicated in 28 patients (82 %). Complications occurred in 3/34 patients (9 %): two perforations, one delayed bleeding. In all, 19 patients (56 %) developed dysphagia, which was resolved with dilatation or stent placement. During a median follow-up period of 23 months (IQR 15 – 41 months), HGIN / early cancer recurred in three patients (9 %): two were retreated with endoscopic resection and one patient was referred for curative surgery. Five patients (15 %) had recurrence of nondysplastic Barrett’s esophagus. At the end of the follow-up period all patients were free of HGIN / early cancer (one patient after surgery), and 23 patients (68 %) had complete endoscopic and histological eradication of Barrett’s esophagus.

Conclusions: SRER resulted in complete eradication of HGIN/early cancer in all patients, and eradication of Barrett’s esophagus in a majority of cases. A significant number of patients develop dysphagia, which can be successfully treated endoscopically.

References

  • 1 Holmes R S, Vaughan T L. Epidemiology and pathogenesis of esophageal cancer.  Semin Radiat Oncol. 2007;  17 2-9
    CrossrefPubMedGoogle Scholar
  • 2 Drewitz D J, Sampliner R E, Garewal H S. et al . The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years.  Am J Gastroenterol. 1997;  92 212-215
    PubMedGoogle Scholar
  • 3 Hameeteman W, Tytgat G N, Houthoff H J. et al . Barrett’s esophagus: development of dysplasia and adenocarcinoma.  Gastroenterology. 1989;  96 (5 Pt 1) 1249-1256
    PubMedGoogle Scholar
  • 4 Buttar N S, Wang K K, Lutzke L S. et al . Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus.  Gastrointest Endosc. 2001;  54 682-688
    PubMedGoogle Scholar
  • 5 Peters F P, Kara M A, Rosmolen W D. et al . Endoscopic treatment of high grade dysplasia and early cancer in Barrett’s esophagus.  Gastrointest Endosc. 2005;  61 506-514
    CrossrefPubMedGoogle Scholar
  • 6 Ell C, May A, Pech O. et al . Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer).  Gastrointest Endosc. 2007;  65 3-10
    CrossrefPubMedGoogle Scholar
  • 7 Deprez P H, Aouattah T, Piessevaux H. Endoscopic removal or ablation of oesophageal and gastric superficial tumours.  Acta Gastroenterol Belg. 2006;  69 304-311
    PubMedGoogle Scholar
  • 8 May A, Gossner L, Pech O. et al . Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach.  Eur J Gastroenterol Hepatol. 2002;  14 1085-1091
    CrossrefPubMedGoogle Scholar
  • 9 Peters F P, Kara M A, Rosmolen W D. et al . Poor results of 5-ALA-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett’s esophagus after endoscopic resection.  Endoscopy. 2005;  37 418-424
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Gossner L, Stolte M, Sroka R. et al . Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid.  Gastroenterology. 1998;  114 448-455
    PubMedGoogle Scholar
  • 11 Ackroyd R, Kelty C J, Brown N J. et al . Eradication of dysplastic Barrett’s oesophagus using photodynamic therapy: long-term follow-up.  Endoscopy. 2003;  35 496-501
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Overholt B F, Panjehpour M, Halberg D L. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results.  Gastrointest Endosc. 2003;  58 183-188
    CrossrefPubMedGoogle Scholar
  • 13 Pech O, Gossner L, May A. et al . Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia.  Gastrointest Endosc. 2005;  62 24-30
    CrossrefPubMedGoogle Scholar
  • 14 Pereira-Lima J C, Busnello J V, Saul C. et al . High power setting argon plasma coagulation for the eradication of Barrett’s esophagus.  Am J Gastroenterol. 2001;  96 1662-1663
    PubMedGoogle Scholar
  • 15 Spechler S J. Thermal ablation of Barrett’s esophagus: a heated debate.  Am J Gastroenterol. 2006;  101 1770-1772
    CrossrefPubMedGoogle Scholar
  • 16 Manner H, May A, Rabenstein T. et al . Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy.  Scand J Gastroenterol. 2007;  42 397-405
    CrossrefPubMedGoogle Scholar
  • 17 Krishnadath K K, Wang K K, Taniguchi K. et al . Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy.  Gastroenterology. 2000;  119 624-630
    CrossrefPubMedGoogle Scholar
  • 18 Garewal H, Ramsey L, Sharma P. et al . Biomarker studies in reversed Barrett’s esophagus.  Am J Gastroenterol. 1999;  94 2829-2833
    CrossrefPubMedGoogle Scholar
  • 19 Petersen B T, Chuttani R, Croffie J. et al . Photodynamic therapy for gastrointestinal disease.  Gastrointest Endosc. 2006;  63 927-932
    CrossrefPubMedGoogle Scholar
  • 20 Van Laethem J L, Peny M O, Salmon I. et al . Intramucosal adenocarcinoma arising under squamous re-epithelisation of Barrett’s esophagus.  Gut. 2000;  46 574-577
    CrossrefPubMedGoogle Scholar
  • 21 Van Hillegersberg R, Haringsma J, ten Kate F J. et al . Invasive adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus.  Dig Surg. 2003;  20 440-444
    PubMedGoogle Scholar
  • 22 Inoue H, Endo M. Endoscopic esophageal mucosal resection using a transparent tube.  Surg Endosc. 1990;  4 198-291
    CrossrefPubMedGoogle Scholar
  • 23 Seewald S, Akaraviputh T, Seitz U. et al . Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma.  Gastrointest Endosc. 2003;  57 854-859
    CrossrefPubMedGoogle Scholar
  • 24 Giovannini M, Bories E, Pesenti C. et al . Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.  Endoscopy. 2004;  36 782-787
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Peters F P, Kara M A, Rosmolen W D. et al . Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia. A prospective study.  Am J Gastro. 2006;  101 1449-1457
    CrossrefPubMedGoogle Scholar
  • 26 Soehendra N, Seewald S, Groth S. et al . Use of modified multiband ligator facilitates circumferential EMR in Barrett’s esophagus.  Gastrointest Endosc. 2006;  63 847-852
    CrossrefPubMedGoogle Scholar
  • 27 Lopes C V, Hela M, Pesenti C. et al . Circumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma.  Surg Endosc. 2007;  21 820-824
    CrossrefPubMedGoogle Scholar
  • 28 Larghi A, Lightdale C J, Ross A S. et al . Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.  Endoscopy. 2007;  39 1086-1091
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Peters F P, Krishnadath K K, Rygiel A M. et al . Stepwise radical endoscopic resection of the complete Barrett’s esophagus with early neoplasia Tuccessfully eradicates pre-existing genetic abnormalities.  Am J Gastroenterol. 2007;  102 1853-1861
    CrossrefPubMedGoogle Scholar
  • 30 . The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.  Gastrointest Endosc. 2003;  58 (6 Suppl) S3-43
    CrossrefPubMedGoogle Scholar

P. H. DeprezMD 

Department of Gastroenterology and Hepatology, Université Catholique de Louvain, Saint Luc

Ave Hippocrate 10
Brussels
Belgium 1200

Fax: +32-2-7648927

Email: deprez@gaen.ucl.ac.be

      >